Skip to content

Study to Evaluate Dietary Modification in Patients With Functional Dyspepsia.

A Prospective, Randomized, Investigator Blinded, Controlled Trial to Evaluate the Effectiveness of Dietary Modification in Patients With Functional Dyspepsia

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02863822
Enrollment
0
Registered
2016-08-11
Start date
2016-09-30
Completion date
2018-06-30
Last updated
2024-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Modification, Dyspepsia

Keywords

Functional Dyspepsia, Low FODMAP, Dietary Modification

Brief summary

The purpose of this study is to evaluate the effectiveness of the low fermentable oligo-di-monosaccharides and polyols (FODMAP) diet in functional dyspepsia (FD). The investigators will compare education in the low FODMAP diet to a standard healthy diet for improving symptoms in FD.

Detailed description

Functional Dyspepsia (FD) is defined by the Rome III criteria as bothersome postprandial fullness, early satiation, epigastric pain, or epigastric burning in the absence of structural or systemic disease that can explain the symptoms. These symptoms have been present for at least 3 months with symptom onset 6 months prior to the diagnosis. The low fermentable oligo-di-monosaccharides and polyols (FODMAP) diet has been studied in irritable bowel syndrome (IBS) patients and has been shown to have modest benefit in a limited number of small studies. The diet is generally started by complete elimination of fructose, lactose, fructans, galactans, and polyols. Following symptom improvement, these groups are reintroduced one at a time while the patient monitors for symptoms. Although the low FODMAP diet has never been formally studied in patients with functional dyspepsia, we have noted the FD patients report improvement in their symptoms on the diet. This improvement could be explained by reduction in duodenal and gastric distention with the low FODMAP diet or a change in the duodenal flora. To date, there have been no randomized trials evaluating dietary modification in FD. The purpose of this study is to evaluate the efficacy of the low FODMAP diet in functional dyspepsia. The investigator's hypothesis is that the addition of the FODMAP diet to standard medical treatment will result in improved symptom control in patients with functional dyspepsia.

Interventions

BEHAVIORALLow FODMAP Diet

Subjects in the experimental arm, will be educated in the low fermentable oligo-di-monosaccharides and polyols (FODMAP) diet.

BEHAVIORALChoose My Plate Diet

Subjects in the active comparator arm will be educated in the ChooseMyPlate.gov Diet.

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women 18 years and older * Diagnosis of FD with either PDS or EPS as measured by Rome III Criteria * Patients describing inadequate relief of dyspepsia symptoms * Endoscopy performed in the last 3 years and negative for an organic cause for dyspeptic symptoms * H pylori negative by non-invasive testing or biopsy. Patients with a history of successfully eradicated H pylori will be included if follow-up testing by stool antigen, urea breath testing, or biopsy is negative * Celiac disease excluded by serologies or biopsy

Exclusion criteria

* Patients with IBS predominant symptoms that are not well controlled * Patients with a diagnosis of GERD who have uncontrolled heartburn * History of esophagitis, ulcer disease, or other organic upper GI disease, including a diagnosis of celiac disease, gastroparesis, or vascular disorders of the upper GI tract * History of surgery involving the esophagus, stomach, or duodenum * Known lactose intolerance, unless symptoms persist on a lactose free diet * Known fructose intolerance unless symptoms persist on a fructose free diet * Patients undergoing active titration of any medications * Pregnant or breastfeeding women * Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Self report of adequate reliefWeek 7 (after 4 weeks of diet modification)Self report of adequate relief of dyspepsia symptoms for the previous 7 days. This information will be collected at week 7. This measure is considered clinically relevant and has been tested for responsiveness in FD

Secondary

MeasureTime frameDescription
Improvement in the NDI short formWeek 7 (after 4 weeks of diet modification)The NDI short form is a validated questionnaire used to determine the severity of symptoms related to dyspepsia. It can be used to evaluate change over time.
Improvement in the Global Overall Symptom ScaleWeek 7 (after 4 weeks of diet modification)
Continued Improvement in the Global Overall Symptom ScaleWeek 10 (after low FODMAP reintroduction)
Continued Improvement in the NDI short formWeek 10 (after low FODMAP reintroduction)The NDI short form is a validated questionnaire used to determine the severity of symptoms related to dyspepsia. It can be used to evaluate change over time.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026